NCT05606510

Brief Summary

The goal of this randomized control trial is to determine the effects of a mindful exercise program on physical (back pain and balance) and psychological (mindfulness, kinesiophobia, anxiety and depression) consequences of primary osteoporosis in older patients. The main questions it aims to answer are:

  • What are the levels of pain, balance, mindfulness, kinesiophobia, anxiety and depression in older patients with primary osteoporosis?
  • Are there differences in pain, balance, mindfulness, kinesiophobia, anxiety and depression according to sociodemographic-clinical characteristics of the patients?
  • Are there differences in pain, balance, mindfulness, kinesiophobia, anxiety and depression between the intervention (mindful exercise) and control (usual care) groups of older patients with primary osteoporosis? 128 participants who meet the criteria will be recruited from the pain department of a Tertiary A level provincial Traditional Chinese Medicine hospital in Mainland China, and randomly assigned to the intervention group or control group. All patients in both groups will receive usual care, including routine medicine and nursing care. The study will last for 12 weeks (one-week training in hospital and 11-week on-line sessions at home) and 4-week follow up. Patients in the intervention group will receive a group-based mindful exercise which will be conducted 5 times per week, 30 minutes per session, and co-led by a mindfulness-trained main researcher and a professional exercise specialist for the first week (week 1) hospitalization. When they discharge, on-line sessions (week 2-12) will be conducted by the main researcher from Monday to Friday. Patients and primary caregivers will be taught how to use 'Tencent meet' software. Upon discharge, a WeChat group will be set up to notify the exercise time and send the links for the online sessions. Those in the control group will received routine medicine and nursing care as usual, and only be taught on the hospital-recommended movements (physical stretching) and encouraged to do it at home on their own. All the variables (pain, mindfulness, kinesiophobia, anxiety and depression) and the TUG test (balance) will be measured at the following time point: baseline (Time 1), week 4 (Time 2), week 8 (Time 3), week 12 (Time 4, immediately post-intervention) and week 16 (Time 5, 4 weeks after the intervention) for the two groups of patients. The study will obtain ethical clearance from the study setting, as well as written consent from the participants. Descriptive statistics will be computed for all variables. Normality and homogeneity of the variances will be tested using the Shapiro-Wilk and Levene tests, respectively. The data will be analyzed using mixed-model analysis of variance to test the main and interaction effects of group (independent factor) and time (repeated-measures factor) on the dependent variables. The findings of the study would certainly have implications for the treatment of older patients with primary osteoporosis, especially non-pharmacological treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 4, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 16, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

9 months

First QC Date

October 21, 2022

Last Update Submit

May 9, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change of back pian level

    Back pain will be measured using the Chinese version of Global Pain Scale (GPS), which has 20 items with four dimensions: pain, feelings, clinical outcomes, activities. Each item is rate with 11-point scale ranging from 0-10. The total score is 0 to 200 points and the higher the score, the higher the pain intensity and interference.

    0,4,8,12,16 weeks post-intervention

  • Change of balance ability

    Balance will be measured by the Timed Up and Go (TUG) test using the following equipment: stopwatch, standard chair (chair with about 46 cm high and the armrest about 20 cm high), the measured distance of 3 meters (Zakaria et al., 2015). There is no official cut-off for TUG, but previous study implied that a score of \>12 seconds indicates a high risk of falling.

    0,4,8,12,16 weeks post-intervention

  • Change of mindfulness level

    Mindfulness will be measured using the Chinese version the short form of the Five Facet Mindfulness Questionnaire (FFMQ-SF), which consists 20 items with five dimensions: Observing; Describing; Acting with-awareness; Nonjudging to inner experience; Nonreacting to inner experience. Each item is scored on a 5-point Likert-type scale ranging from 1 (never or very rarely true) to 5 (very often or always true) with a total score of 20 to 100. The higher scores indicating a high level of mindfulness.

    0,4,8,12,16 weeks post-intervention

  • Change of kinesiophobia level

    Kinesiophobia will be measured using the Chinese version of the Tampa Scale of Kinesiophobia-11 (TSK-11) which contains 11 items with three dimensions: Somatic focus (6 items), Activity avoidance (3 items), and Avoidance beliefs (2 items). Each item was rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree). A total score ranging from 11 to 44. The higher scores correspond to a greater perceived level of kinesiophobia.

    0,4,8,12,16 weeks post-intervention

Secondary Outcomes (1)

  • Change of anxiety and depression level

    0,4,8,12,16 weeks post-intervention

Study Arms (2)

Intervention

EXPERIMENTAL

A 12-week, group-based mindful exercise program which will be conducted 5 times per week, 30 minutes per session.

Other: Mindful exercise

Control

OTHER

Routine medicine, nursing care, and hospital-recommended exercise.

Other: usual care

Interventions

In this study, a modified mindful exercise (ME) program based on mindful standing yoga refers to a type of exercise that aims to harmonize the body and mind through the effect of mindfulness meditation and stretching-awareness to carry on the actual moment through body movement and surroundings without any judgement.

Intervention

Routine medicine and nursing care; as well as hospital-recommended movements (physical stretching).

Control

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 60 years and above, and can use smart phone.
  • Patients diagnosed as primary osteoporosis with mild to moderate back pain \[Numeric Rating Scale (NRS) score 1-6\] for more than 3 months.
  • Patients with low risk of falls that measured by the Morse Fall Risk Scale (MFS) \[MFS score \<25\].
  • Patients with no visual, hearing, mental problems or cognitive impairment \[assessed using Short Portable Mental Status Questionnaire\] that could prevent communication.
  • Patients with no secondary diseases resulting in decreased mobility, functional status.
  • Patients with no neurological or muscle diseases, ability to continuously attend the exercise program.

You may not qualify if:

  • Patients with secondary osteoporosis or other diseases that can interfere with bone metabolism.
  • Patients taking of concomitant medication that affected calcium and bone metabolism.
  • Patients who presence of medical conditions that could have interfered with the outcomes of the trial.
  • Patients with cardiovascular or cerebrovascular disease (blood pressure higher than 160/110 mmHg on medication, with systolic blood pressure less than 90 mmHg, with heart stents or body implantation, with a history of thrombosis within the past 6 months).
  • Patients who are in the rehabilitation period for surgical intervention.
  • Patients who have not recovered from muscle strain, joint injuries or fractures (fractures within the past three months).
  • Patients undergoing other psychotherapy, including taking psychotropic medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine

Kunming, Yunnan, 650021, China

RECRUITING

MeSH Terms

Conditions

Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fang Fei Lyu

    Yunnan University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2022

First Posted

November 4, 2022

Study Start

February 16, 2023

Primary Completion

October 30, 2023

Study Completion

April 30, 2024

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations